Quetiapine Fumarate Extended-Release Tablets
Treatment of schizophrenia: This product is effective for positive symptoms of schizophrenia and also has a certain effect on negative symptoms. It can also alleviate the emotional symptoms associated with schizophrenia, such as depression, anxiety and cognitive deficits. Treatment of depressive episodes in bipolar affective disorder: This product can rapidly control depressive symptoms in bipolar affective disorder. It is effective for both bipolar I and II patients.
Product Category：
Product Description
[Product Name] Blanx®
[Generic Name] Quetiapine Fumarate Extended-Release Tablets
[Approval No.] GYZZ H20203418
[Dosage and Administration] The tablets should be swallowed whole, not broken, chewed or crushed, taken with or without food
[Age of Use] Over 18 years old, see package insert for details
[Strength] 200 mg*20 tablets/carton
[Storage] Store in airtight containers at room temperature
[Shelf Life] 36 months
[Manufacturer] Nanyang Tianheng Pharmaceutical Factory, Tianheng Academy of Pharmaceutical Sciences Co., Ltd.
[China General Distributor] Shenzhen Foncoo Pharmaceutical Co., Ltd.
ONLINE MESSAGE
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible
Related Products
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No. 1001, Xueyuan Avenue, Changyuan Community, Taoyuan Street, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED